Literature DB >> 31605029

CDK4/6 inhibitors prolong OS.

David Killock1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31605029     DOI： 10.1038/s41571-019-0288-z

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analysis of the TAILORx Randomized Clinical Trial.

Authors:  Joseph A Sparano; Robert J Gray; Della F Makower; Kathy S Albain; Thomas J Saphner; Sunil S Badve; Lynne I Wagner; Virginia G Kaklamani; Maccon M Keane; Henry L Gomez; Pavan S Reddy; Timothy F Goggins; Ingrid A Mayer; Deborah L Toppmeyer; Adam M Brufsky; Matthew P Goetz; Jeffrey L Berenberg; Catalin Mahalcioiu; Christine Desbiens; Daniel F Hayes; Elizabeth C Dees; Charles E Geyer; John A Olson; William C Wood; Tracy Lively; Soonmyung Paik; Matthew J Ellis; Jeffrey Abrams; George W Sledge
Journal:  JAMA Oncol       Date:  2020-03-01       Impact factor: 31.777
  1 in total
  1 in total

Review 1.  'Breast Cancer Resistance Likelihood and Personalized Treatment Through Integrated Multiomics'.

Authors:  Sabba Mehmood; Muhammad Faheem; Hammad Ismail; Syeda Mehpara Farhat; Mahwish Ali; Sidra Younis; Muhammad Nadeem Asghar
Journal:  Front Mol Biosci       Date:  2022-04-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.